Anthem Biosciences' Credit Ratings Revised by ICRA; Multiple Instruments Rated AA Stable

Anthem Biosciences' Credit Ratings Revised by ICRA; Multiple Instruments Rated AA Stable

Anthem Biosciences' Credit Ratings Revised by ICRA; Multiple Instruments Rated AA Stable​

Anthem Biosciences Ltd has received revised credit ratings for several of its bank facilities from ICRA Limited. The agency assessed various instruments, resulting in upgrades and stable outlooks across multiple categories, as part of its rating assessment.

ICRA’s updated evaluation covered fund-based working capital, term loans, non-fund based limits, and unallocated limits. The ratings reflect an improvement or stability following previous assessments for these specified facilities.

The key aspects of the revised credit ratings are detailed below:

InstrumentRated Amount (Rs. Crores)RatingKey Change/Status
Long Term/Short Term - Fund Based - Working Capital175[ICRA]AA (Stable)Upgraded from [ICRA]AA- (Positive); Outlook revised to Stable.
Long Term - Fund Based - Term Loan67.50[ICRA]AA (Stable)Upgraded from [ICRA]AA- (Positive); Assigned for enhanced limit.
Short Term - Non-Fund based others10[ICRA]A1+Assigned for enhanced limit.
Long Term/ Short Term - Unallocated23[ICRA]AA (Stable)Upgraded from [ICRA]AA- (Positive); Assigned for enhanced limit.

The rating for the Long Term/Short Term - Fund Based - Working Capital facility was revised to [ICRA]AA (Stable), marking an upgrade from [ICRA]AA- (Positive). The outlook for this instrument was also revised from Positive to Stable.

Similarly, the Long Term - Fund Based - Term Loan received a rating of [ICRA]AA (Stable), which is an upgrade from [ICRA]AA- (Positive). This limit has been assigned for enhanced status.

In addition, the company’s Short Term - Non-Fund based others were rated at [ICRA]A1+ and were assigned for an enhanced limit. The Unallocated Limits, amounting to Rs. 23 Crores, were rated as [ICRA]AA (Stable), upgraded from [ICRA]AA- (Positive) with a revised outlook of Stable.

These rating assessments are specific to the terms and conditions of each instrument and remain subject to review by ICRA based on new information or circumstances. The ratings hold specific relevance to the terms and size of the rated instruments as indicated in the relevant agreement.

ANTHEM Stock Price Movement​

As of 1:03 PM, Anthem Biosciences Limited shares are slipping by 0.27%, currently trading at ₹770.25. The stock saw a total traded volume of 234,986 shares during this live market session.
 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.

Last edited by a moderator:
Back
Top